Dr. James Bus is director of external technology at The Dow Chemical Co. and an adjunct professor of pharmacology and toxicology at Michigan State University. Dr. Bus served as president of the Society of Toxicology in 1996-1997 and as president of the American Board of Toxicology in 1986-1987. He is a current member of the U.S. Environmental Protection Agency Chartered Science Advisory Board, the Science Advisory Board of the U.S. Food and Drug Administration National Center for Toxicological Research, and the National Academy of Sciences Board of Environmental Sciences and Toxicology. Dr. Bus received his doctorate in pharmacology from Michigan State University in 1975. He has authored or co-authored more than 100 research papers, reviews and books.

By Dr. James Bus

The Opportunities and Limitations of Biomonitoring

Remarkable advances in analytical chemistry now make it possible to measure minute levels of both natural and synthetic compounds in human tissue and body fluids. This “biomonitoring” allows researchers to determine more precisely than ever the degree to which individuals have been exposed to specific chemicals in the environment, and how exposures change over time. Consequently, federal and state officials increasingly regard biomonitoring as a potential new underpinning of environmental and public health regulations. … more